Skip to main content
. 2021 Jun 7;2021:5537737. doi: 10.1155/2021/5537737

Figure 1.

Figure 1

(a) The possible structure of the ruthenium-fluvastatin complex. (b–d) Receptor-ligand hydrogen bonding interactions of Ru-flu with active site residues of gamma-synuclein.